CLAS.H — Claritas Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Claritas Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2016 December 31st	2017 December 31st	2018 December 31st	2019 December 31st	2020 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.673	3.69	0.227	0.032	0.005
Net Total Receivables	4.14	0.113	0.52	0.121	0.206
Prepaid Expenses
Total Current Assets	4.81	3.8	0.747	0.153	0.975
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	4.81	65.3	59.6	25.3	10.4
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.9	4.01	7.82	5.76	7.13
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	1.9	76.9	49.8	28.7	8.94
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	2.92	-11.6	9.76	-3.44	1.51
Total Liabilities & Shareholders' Equity	4.81	65.3	59.6	25.3	10.4
Total Common Shares Outstanding